Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 09-2004 | 06-2004 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 2 | 1,940 | 14,020 |
| Marketable Securities | 31,890 | 32,750 | 19,740 |
| Receivables | 290 | 270 | 160 |
| Other current assets | 1,619 | 1,370 | 2,350 |
| TOTAL | $33,800 | $36,330 | $36,270 |
| Non-Current Assets | |||
| PPE Net | 5,980 | N/A | N/A |
| Other Non-Current Assets | 1,450 | 1,490 | 1,390 |
| TOTAL | $7,430 | $1,490 | $1,390 |
| Total Assets | $38,110 | $41,000 | $40,820 |
| Liabilities | |||
| Current Liabilities | |||
| Short Term Debt | 0 | 2 | 5 |
| Accounts payable and accrued liabilities | 2,160 | 1,960 | 1,820 |
| Other current liabilities | 1,320 | 1,820 | 2,310 |
| TOTAL | $3,710 | $3,800 | $4,150 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 1,660 | 1,740 | 1,700 |
| TOTAL | $1,665 | $1,748 | $1,710 |
| Total Liabilities | $5,380 | $5,550 | $5,870 |
| Shareholders' Equity | |||
| Common Shares | 57,250 | 56,890 | 53,710 |
| Retained earnings | -28,000 | -24,710 | -21,810 |
| TOTAL | $32,730 | $35,440 | $34,940 |
| Total Liabilities And Equity | $38,110 | $40,990 | $40,810 |